In the immune microenvironment of bone metastasis from prostate cancer, Tregs can translocate to the bone marrow through C-X-C chemokine receptor 4 (CXCR4)/C-X-C Motif Chemokine 12 (CXCL12) (47). This evidence concerns the gene CXCL12 and prostate carcinoma.